Big Pharma's big headache: Beating back the generics

From the Globe and Mail:
If you want to get an idea of the biggest challenge facing Big Pharma, just take a look at Pfizer Inc., the world's biggest drug maker, and Lipitor, the world's best-selling drug, which contributed $11-billion (U.S.) of the company's $52-billion in sales last year.

Any day now, Judge Joseph Farnan of the U.S. District Court of Delaware will rule on a case brought by India's generic giant Ranbaxy Laboratories Ltd. to invalidate the patents on Lipitor, which is prescribed to lower cholesterol levels in the blood. If Pfizer prevails, as it did in a British court recently, its patents would stand until 2011. But the prevailing view on Wall Street is that anything is possible because of differences in British and U.S. patent law. ...more